Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 206

1.

Improving thromboprophylaxis using atrial fibrillation diagnostic capabilities in implantable cardioverter-defibrillators: the multicentre Italian ANGELS of AF Project.

Boriani G, Santini M, Lunati M, Gasparini M, Proclemer A, Landolina M, Padeletti L, Botto GL, Capucci A, Bianchi S, Biffi M, Ricci RP, Vimercati M, Grammatico A, Lip GY; Italian ClinicalService Project..

Circ Cardiovasc Qual Outcomes. 2012 Mar 1;5(2):182-8. doi: 10.1161/CIRCOUTCOMES.111.964205. Epub 2012 Feb 28.

2.

Very low risk of thromboembolic events in patients undergoing successful catheter ablation of atrial fibrillation with a CHADS2 score ≤3: a long-term outcome study.

Saad EB, d'Avila A, Costa IP, Aryana A, Slater C, Costa RE, Inácio LA Jr, Maldonado P, Neto DM, Camiletti A, Camanho LE, Polanczyk CA.

Circ Arrhythm Electrophysiol. 2011 Oct;4(5):615-21. doi: 10.1161/CIRCEP.111.963231. Epub 2011 Aug 13.

3.

Incidence of stroke in paroxysmal versus sustained atrial fibrillation in patients taking oral anticoagulation or combined antiplatelet therapy: an ACTIVE W Substudy.

Hohnloser SH, Pajitnev D, Pogue J, Healey JS, Pfeffer MA, Yusuf S, Connolly SJ; ACTIVE W Investigators..

J Am Coll Cardiol. 2007 Nov 27;50(22):2156-61. Epub 2007 Nov 13.

4.

Detection of previously undiagnosed atrial fibrillation in patients with stroke risk factors and usefulness of continuous monitoring in primary stroke prevention.

Ziegler PD, Glotzer TV, Daoud EG, Singer DE, Ezekowitz MD, Hoyt RH, Koehler JL, Coles J Jr, Wyse DG.

Am J Cardiol. 2012 Nov 1;110(9):1309-14. doi: 10.1016/j.amjcard.2012.06.034. Epub 2012 Jul 20.

PMID:
22819433
5.

Diagnosis and management of atrial fibrillation by primary care physicians in Italy : a retrospective, observational analysis.

Piccinocchi G, Laringe M, Guillaro B, Arpino G, Piccinocchi R, Nigro G, Calabrò P.

Clin Drug Investig. 2012 Nov;32(11):771-7. doi: 10.1007/s40261-012-0005-5.

6.

Anticoagulant and antiplatelet therapy for stroke prevention in atrial fibrillation patients in the clinical practice of a single district hospital in Poland.

Bednarski J, Cieszewska E, Strzelecki A, Filipiak KJ.

Kardiol Pol. 2013;71(12):1260-5. doi: 10.5603/KP.a2013.0179. Epub 2013 Aug 30.

7.
8.

Can we predict stroke in atrial fibrillation?

Lip GY.

Clin Cardiol. 2012 Jan;35 Suppl 1:21-7. doi: 10.1002/clc.20969. Review.

9.

Risks and benefits of anticoagulation in atrial fibrillation: insights from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry.

Cullen MW, Kim S, Piccini JP Sr, Ansell JE, Fonarow GC, Hylek EM, Singer DE, Mahaffey KW, Kowey PR, Thomas L, Go AS, Lopes RD, Chang P, Peterson ED, Gersh BJ; ORBIT-AF Investigators..

Circ Cardiovasc Qual Outcomes. 2013 Jul;6(4):461-9. doi: 10.1161/CIRCOUTCOMES.113.000127. Epub 2013 Jun 11.

10.
11.

[Management of thromboembolic risk in patients with atrial fibrillation in Italy: baseline data from the PREFER in AF European Registry].

De Caterina R, Renda G, Sangiuolo R, Attena E, Di Lecce L, Romeo F; Steering Committee del Registro Europeo PREFER in AF (vedi Appendice 1)..

G Ital Cardiol (Rome). 2014 Feb;15(2):99-109. doi: 10.1714/1424.15779. Italian.

PMID:
24625849
12.

Selecting patients with atrial fibrillation for anticoagulation: stroke risk stratification in patients taking aspirin.

Gage BF, van Walraven C, Pearce L, Hart RG, Koudstaal PJ, Boode BS, Petersen P.

Circulation. 2004 Oct 19;110(16):2287-92. Epub 2004 Oct 11.

13.

Anticoagulation in "real world" patients with atrial fibrillation in Italy: results from the ISPAF (Indagine Sicoa Paziente Con Fibrillazione Atriale) survey study.

Volterrani M, Iellamo F, Rosano G, Guarini P, Pusineri E, Bonassi S, Chimini C, Zaccà F, Proto C; SICOA (Società Italiana Cardiologia Ospedalità Accreditata) Investigators..

Int J Cardiol. 2013 Oct 12;168(5):4729-33. doi: 10.1016/j.ijcard.2013.07.169. Epub 2013 Jul 26.

PMID:
23948115
14.
15.

Oral anticoagulation use by patients with atrial fibrillation in Germany. Adherence to guidelines, causes of anticoagulation under-use and its clinical outcomes, based on claims-data of 183,448 patients.

Wilke T, Groth A, Mueller S, Pfannkuche M, Verheyen F, Linder R, Maywald U, Kohlmann T, Feng YS, Breithardt G, Bauersachs R.

Thromb Haemost. 2012 Jun;107(6):1053-65. doi: 10.1160/TH11-11-0768. Epub 2012 Mar 8.

PMID:
22398417
16.

Outcomes and safety of antithrombotic treatment in patients aged 80 years or older with nonvalvular atrial fibrillation.

Ruiz Ortiz M, Romo E, Mesa D, Delgado M, Ibáñez CL, Anguita M, Castillo JC, Arizón JM, Suárez de Lezo J.

Am J Cardiol. 2011 May 15;107(10):1489-93. doi: 10.1016/j.amjcard.2011.01.025. Epub 2011 Mar 21.

PMID:
21420049
17.

Impact of new criteria for anticoagulant treatment in atrial fibrillation.

Rodríguez-Mañero M, Cordero A, Bertomeu-González V, Moreno-Arribas J, Bertomeu-Martínez V, Mazón P, Fácila L, Cosín J, Lekuona I, Galve E, González-Juanatey JR.

Rev Esp Cardiol. 2011 Aug;64(8):649-53. doi: 10.1016/j.recesp.2011.03.014. Epub 2011 Jun 8. English, Spanish.

18.

Guideline adherence in antithrombotic treatment after concomitant ablation surgery in atrial fibrillation patients.

van Breugel HN, Gelsomino S, Lozekoot PW, Accord RE, Lucà F, Parise O, Crijns HJ, Maessen JG.

Interact Cardiovasc Thorac Surg. 2014 Mar;18(3):313-20. doi: 10.1093/icvts/ivt522. Epub 2013 Dec 13.

19.

Presence and duration of atrial fibrillation detected by continuous monitoring: crucial implications for the risk of thromboembolic events.

Botto GL, Padeletti L, Santini M, Capucci A, Gulizia M, Zolezzi F, Favale S, Molon G, Ricci R, Biffi M, Russo G, Vimercati M, Corbucci G, Boriani G.

J Cardiovasc Electrophysiol. 2009 Mar;20(3):241-8. doi: 10.1111/j.1540-8167.2008.01320.x. Epub 2008 Oct 30.

PMID:
19175849
20.

Reasons for undertreatment with oral anticoagulants in frail geriatric outpatients with atrial fibrillation: a prospective, descriptive study.

Tulner LR, Van Campen JP, Kuper IM, Gijsen GJ, Koks CH, Mac Gillavry MR, van Tinteren H, Beijnen JH, Brandjes DP.

Drugs Aging. 2010 Jan 1;27(1):39-50. doi: 10.2165/11319540-000000000-00000. Review.

PMID:
20030431

Supplemental Content

Support Center